Logo image of UONEK

URBAN ONE INC (UONEK) Stock Fundamental Analysis

NASDAQ:UONEK - Nasdaq - US91705J2042 - Common Stock - Currency: USD

0.4728  +0 (+0.38%)

After market: 0.4651 -0.01 (-1.63%)

Fundamental Rating

3

UONEK gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 97 industry peers in the Media industry. UONEK has an average financial health and profitability rating. UONEK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year UONEK has reported negative net income.
In the past year UONEK had a positive cash flow from operations.
In multiple years UONEK reported negative net income over the last 5 years.
Each year in the past 5 years UONEK had a positive operating cash flow.
UONEK Yearly Net Income VS EBIT VS OCF VS FCFUONEK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -11.16%, UONEK is doing worse than 69.07% of the companies in the same industry.
UONEK has a Return On Equity of -61.65%. This is in the lower half of the industry: UONEK underperforms 72.16% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.25%, UONEK is in the better half of the industry, outperforming 75.26% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for UONEK is in line with the industry average of 6.66%.
Industry RankSector Rank
ROA -11.16%
ROE -61.65%
ROIC 7.25%
ROA(3y)-2.73%
ROA(5y)-1.22%
ROE(3y)-16.58%
ROE(5y)-8.39%
ROIC(3y)7.75%
ROIC(5y)8.24%
UONEK Yearly ROA, ROE, ROICUONEK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

1.3 Margins

UONEK has a Operating Margin of 16.94%. This is amongst the best in the industry. UONEK outperforms 84.54% of its industry peers.
In the last couple of years the Operating Margin of UONEK has declined.
UONEK has a better Gross Margin (69.93%) than 86.60% of its industry peers.
In the last couple of years the Gross Margin of UONEK has remained more or less at the same level.
Industry RankSector Rank
OM 16.94%
PM (TTM) N/A
GM 69.93%
OM growth 3Y-14.33%
OM growth 5Y-9.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.4%
GM growth 5Y-0.17%
UONEK Yearly Profit, Operating, Gross MarginsUONEK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

5

2. Health

2.1 Basic Checks

UONEK has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
UONEK has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, UONEK has about the same amount of shares outstanding.
Compared to 1 year ago, UONEK has a worse debt to assets ratio.
UONEK Yearly Shares OutstandingUONEK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
UONEK Yearly Total Debt VS Total AssetsUONEK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.24, we must say that UONEK is in the distress zone and has some risk of bankruptcy.
UONEK has a worse Altman-Z score (-0.24) than 73.20% of its industry peers.
UONEK has a debt to FCF ratio of 19.14. This is a negative value and a sign of low solvency as UONEK would need 19.14 years to pay back of all of its debts.
UONEK has a Debt to FCF ratio of 19.14. This is comparable to the rest of the industry: UONEK outperforms 54.64% of its industry peers.
A Debt/Equity ratio of 3.39 is on the high side and indicates that UONEK has dependencies on debt financing.
UONEK's Debt to Equity ratio of 3.39 is on the low side compared to the rest of the industry. UONEK is outperformed by 74.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.39
Debt/FCF 19.14
Altman-Z -0.24
ROIC/WACC1.12
WACC6.49%
UONEK Yearly LT Debt VS Equity VS FCFUONEK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

UONEK has a Current Ratio of 2.67. This indicates that UONEK is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.67, UONEK belongs to the best of the industry, outperforming 81.44% of the companies in the same industry.
A Quick Ratio of 2.67 indicates that UONEK has no problem at all paying its short term obligations.
The Quick ratio of UONEK (2.67) is better than 81.44% of its industry peers.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2.67
UONEK Yearly Current Assets VS Current LiabilitesUONEK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1

3. Growth

3.1 Past

The earnings per share for UONEK have decreased strongly by -5605.76% in the last year.
Looking at the last year, UONEK shows a decrease in Revenue. The Revenue has decreased by -5.88% in the last year.
Measured over the past years, UONEK shows a small growth in Revenue. The Revenue has been growing by 0.58% on average per year.
EPS 1Y (TTM)-5605.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-254.68%
Revenue 1Y (TTM)-5.88%
Revenue growth 3Y0.7%
Revenue growth 5Y0.58%
Sales Q2Q%-2.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UONEK Yearly Revenue VS EstimatesUONEK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2

4. Valuation

4.1 Price/Earnings Ratio

UONEK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UONEK Price Earnings VS Forward Price EarningsUONEK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UONEK is valued cheaply inside the industry as 94.85% of the companies are valued more expensively.
100.00% of the companies in the same industry are more expensive than UONEK, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.68
EV/EBITDA 3.42
UONEK Per share dataUONEK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for UONEK!.
Industry RankSector Rank
Dividend Yield N/A

URBAN ONE INC

NASDAQ:UONEK (5/9/2025, 8:25:43 PM)

After market: 0.4651 -0.01 (-1.63%)

0.4728

+0 (+0.38%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-27 2025-03-27/bmo
Earnings (Next)05-13 2025-05-13
Inst Owners26.92%
Inst Owner Change-0.01%
Ins Owners52.91%
Ins Owner Change-2.49%
Market Cap20.60M
Analysts84.44
Price TargetN/A
Short Float %0.15%
Short Ratio0.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF 0.68
P/OCF 0.55
P/B 0.12
P/tB N/A
EV/EBITDA 3.42
EPS(TTM)-2.28
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.69
FCFY146.86%
OCF(TTM)0.86
OCFY181.93%
SpS10.32
BVpS3.92
TBVpS-9.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.16%
ROE -61.65%
ROCE 9.17%
ROIC 7.25%
ROICexc 8.68%
ROICexgc 49.53%
OM 16.94%
PM (TTM) N/A
GM 69.93%
FCFM 6.73%
ROA(3y)-2.73%
ROA(5y)-1.22%
ROE(3y)-16.58%
ROE(5y)-8.39%
ROIC(3y)7.75%
ROIC(5y)8.24%
ROICexc(3y)9.08%
ROICexc(5y)9.37%
ROICexgc(3y)50.06%
ROICexgc(5y)49.19%
ROCE(3y)9.81%
ROCE(5y)10.43%
ROICexcg growth 3Y10.77%
ROICexcg growth 5Y-3.67%
ROICexc growth 3Y0.32%
ROICexc growth 5Y-0.34%
OM growth 3Y-14.33%
OM growth 5Y-9.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.4%
GM growth 5Y-0.17%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 3.39
Debt/FCF 19.14
Debt/EBITDA 4.28
Cap/Depr 12.25%
Cap/Sales 1.61%
Interest Coverage 1.5
Cash Conversion 27.73%
Profit Quality N/A
Current Ratio 2.67
Quick Ratio 2.67
Altman-Z -0.24
F-Score4
WACC6.49%
ROIC/WACC1.12
Cap/Depr(3y)11.58%
Cap/Depr(5y)10.7%
Cap/Sales(3y)1.54%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5605.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-254.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.88%
Revenue growth 3Y0.7%
Revenue growth 5Y0.58%
Sales Q2Q%-2.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-22.1%
EBIT growth 3Y-13.72%
EBIT growth 5Y-9.39%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-46.9%
FCF growth 3Y-25.75%
FCF growth 5Y-10.74%
OCF growth 1Y-42.02%
OCF growth 3Y-22.4%
OCF growth 5Y-8.52%